Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 31;13(5):1169-1172.
doi: 10.21037/tlcr-24-40. Epub 2024 May 17.

Genetic diversity in small cell lung carcinoma

Affiliations
Editorial

Genetic diversity in small cell lung carcinoma

Takuo Hayashi. Transl Lung Cancer Res. .
No abstract available

Keywords: Human papillomavirus (HPV); PTEN; STK11; small cell carcinoma; transformation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-24-40/coif). The author has no conflicts of interest to declare.

Comment on

References

    1. Hirsch FR, Suda K, Wiens J, et al. New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet 2016;388:1012-24. 10.1016/S0140-6736(16)31473-8 - DOI - PubMed
    1. Jordan EJ, Kim HR, Arcila ME, et al. Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. Cancer Discov 2017;7:596-609. 10.1158/2159-8290.CD-16-1337 - DOI - PMC - PubMed
    1. George J, Lim JS, Jang SJ, et al. Comprehensive genomic profiles of small cell lung cancer. Nature 2015;524:47-53. 10.1038/nature14664 - DOI - PMC - PubMed
    1. Mahadevan NR, Knelson EH, Wolff JO, et al. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity. Cancer Discov 2021;11:1952-69. 10.1158/2159-8290.CD-20-0913 - DOI - PMC - PubMed
    1. Gay CM, Stewart CA, Park EM, et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 2021;39:346-360.e7. 10.1016/j.ccell.2020.12.014 - DOI - PMC - PubMed